ABN AMRO INVESTMENT SOLUTIONS

Position in ABT — Abbott Laboratories

CIK 2080520 PARIS CEDEX 008, I0

Position in ABT

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$10,135,839

+$667,407 QoQ

Shares Held

111,702

+21.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#482

of 2,959 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ABN AMRO INVESTMENT SOLUTIONS holds $204,884,588 across 10 Medical Devices names. ABT ranks #4 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	414,338	$130,450,175
2	EW	Edwards Lifesciences Corp	425,838	$38,521,304
3	MDT	Medtronic plc	176,006	$13,768,948
4	ABT	Abbott Laboratories This page	111,702	$10,135,839
5	BSX	Boston Scientific Corp	120,817	$5,156,469
6	DXCM	Dexcom Inc	43,326	$2,918,006
7	IRTC	iRhythm Holdings, Inc.	11,500	$1,367,925
8	STE	STERIS plc	5,414	$1,140,025

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,135,839	111,702	+21.1%	Shares	Other	2026-07-23
2026-03-31	$9,468,432	92,222	+10.9%	Shares	Other	2026-05-12
2025-12-31	$10,417,988	83,151	+305.3%	Shares	Defined	2026-02-06
2025-09-30	$2,747,913	20,516	0.0%	Shares	Defined	2025-11-07
2025-06-30	$2,790,381	20,516	-8.1%	Shares	Defined	2025-08-08
2025-03-31	$2,961,809	22,328	+3.6%	Shares	Defined	2025-08-27
2024-12-31	$2,437,407	21,549	-35.1%	Shares	Defined	2025-09-04
2024-09-30	$3,784,561	33,195	+0.8%	Shares	Defined	2025-09-04
2024-06-30	$3,421,236	32,925	+15.4%	Shares	Defined	2025-09-04
2024-03-31	$3,242,719	28,530	-31.4%	Shares	Defined	2025-09-05
2023-12-31	$4,578,361	41,595	+2.9%	Shares	Defined	2025-09-05
2023-09-30	$3,915,936	40,433	+15.7%	Shares	Defined	2025-11-07
2023-06-30	$3,808,504	34,934	+146.6%	Shares	Defined	2025-09-05
2023-03-31	$1,434,246	14,164	—	Shares	Defined	2025-09-05
No filing history on record for this holder in this stock.